Gabriele Thumann

Fellows and Students

Photo
Fellows and Students


portrait idilIdil Oezsahin, Master student

Ms. Idil Oezsahin is a student in human medicine and master student, working on a toxicity study to determine the tolerability of two gene therapy approaches to treat neovascular and atrophic age-related macular degeneration. The objective of the project is to prepare a toxicity profile using histological, immunohistological and microscopic imaging technics.

 

 

 

 

 

 

 

 

 

portraitTrong-Tin Kevin Steve Vo, Master student

Mr. Trong-Tin Kevin Steve Vo is a student in human medicine and master student, participating in two clinical studies, which aim to 1) identify biomarker patterns in multi-omic profiles from tears to better diagnose active proliferative diabetic retinopathy and 2) investigate the involvement of vasculitis in the manifestation and the severity of COVID-19.

 

 

 

 

 

Maximiliano  Giro Larraz, Master student

Mr. Maximiliano Giro Larraz is a student in human medicine and Master student. He already performed a PREM fellowship in our group and is now working on a systematic review about the pigment epithelial-derived factor and will participate in two clinical studies scheduled to start in fall 2020.

 

 

portrait

Nathan Breuillard, Master student

Mr. Nathan Breuillard, student in biology and Master student, is working on the optimization of culture of low numbers of primary pigment epithelial cells without xenogenic supplements, and will establish the culture of iPS-derived RPE cells in our laboratory.

 

 

 

 

 

 

 

Tobalem_Cut.jpgStéphan Tobalem, MD candidate

Dr. Stéphan Tobalem, specialist in ophthalmology and MD candidate, is trained in the handling of rodents including in vivo ocular behavioral examinations and subretinal transplantation, immunohistology, and biochemical analyses.

 

 

 

 

 

 

 

 

 

Dr Mateusz Kecik, MD candidateKecik.jpg

Dr. Mateusz Kecik, ophthalmologist and MD candidate, is trained in cell culture, immunohistology, biochemical analyses, and the handling of rodents. He has been trained in the quality control  of gene therapeutic medicinal products in preparation of the TargetAMD clinical trial.

 

 

 

 

 

 

 

Robin_Verlooven.jpgRobin Verlooven, MD candidate

Dr. Robin Verlooven, resident in ophthalmology and MD candidate, is trained in cell culture, immunohistology, biochemical analyses, microbiology, molecular biology and bioinformatics. His project aims to culture ocular cells without using xenogenic supplements to improve personalized Advanced Therapy Medicinal Products (ATMP) and refine our experiments following the 3R principles.


Membres du groupe